Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.

about

Hepatitis C virus infection in nephrology patients Viral infection after renal transplantation: surveillance and management.

P2860

Q30486664-A0CD0D73-F8F7-438C-A1AA-4D6A7D0DF67E Q37097708-8E0D8457-733E-4C2A-A988-C8FE12163793

P2860

Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.

Item

http://www.wikidata.org/entity/Q46391838

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Factors accelerating liver fib ...... erapy for chronic hepatitis C.

@en

Factors accelerating liver fib ...... erapy for chronic hepatitis C.

@nl

type

Item

label

Factors accelerating liver fib ...... erapy for chronic hepatitis C.

@en

Factors accelerating liver fib ...... erapy for chronic hepatitis C.

@nl

prefLabel

Factors accelerating liver fib ...... erapy for chronic hepatitis C.

@en

Factors accelerating liver fib ...... erapy for chronic hepatitis C.

@nl

P1476

Factors accelerating liver fib ...... erapy for chronic hepatitis C.

@en

P2093

Anne Boulestin

http://www.w3.org/2001/XMLSchema#string

Dominique Durand

http://www.w3.org/2001/XMLSchema#string

Etienne Chatelut

http://www.w3.org/2001/XMLSchema#string

Janick Selves

http://www.w3.org/2001/XMLSchema#string

Karine Sandres-Saune

http://www.w3.org/2001/XMLSchema#string

Laure Esposito

http://www.w3.org/2001/XMLSchema#string

Michèle Stébenet

http://www.w3.org/2001/XMLSchema#string

P2860

Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin.

Iron absorption and transport-an update.

Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function.

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.

Ribavirin therapy for hepatitis C infection following liver transplantation.

Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.

Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology.

Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C.

P304

61-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.20323

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacques Izopet

Nassim Kamar

Lionel Rostaing

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15778976

http://www.w3.org/2001/XMLSchema#string

Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.

about

P2860

P2860

Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698